Effects of compound 4f on the seizure-like response elicited by kainic acid (KA). by Naoto Arimura (416442)

Subjects:

Gene expression levels of <i>CB1R</i>, <i>CB2R</i>, and <i>MAGL</i> in KA-injected mice treated with compound 4f. by Naoto Arimura (416442)

Subjects:

Map of the study area (shaded in gray). by Fentahun Mengie (20862454)

Subjects:

Proliferation rates of Vasa2+/Piwi1+ were independent on the daytime of the sampling, and mitotic rates were not significantly different upon refeeding of 5- or 20-day-starved poly... by Eudald Pascual-Carreras (12115380)

No significant diurnal rhythmicity of short chain fatty acids in the blood was observed. by Weiran Shan (16969688)

Downregulation of TRIM37 expression exacerbates pathological damage in the MS model. by Lai Jiang (2401513)

Subjects:

Sociodemographic characteristics of participants at baseline, overall and by age group. by Chelsea S. Lutz (16001569)

Subjects:

Symptoms self-reported and/or documented in the electronic health record during the acute COVID-19 illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Average percent relative abundance of top 10 most abundance species of healthy control and stroke patient groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Sociodemographic and clinical characteristics associated with PCC at three months post-acute illness among adults enrolled during Omicron predominance. by Chelsea S. Lutz (16001569)

Subjects:

Rarefaction curves of quality reads per sample at (A) phylum and (B) genus level operational taxonomic units (OTUs), in patient and control samples. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Alpha-diversity analysis at genus level including operational taxonomic unit (OTUs), Chao richness and Shannon diversity indices. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Clinical characteristics of patients and controls. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

(A) Beta-diversity non-metric multidimensional scaling (NMDS) analysis at genus level, and (B) LEfSe for bacterial species biomarkers representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Microbial metabolic potentials categorized according to KEGG (A) level 1 and (B) level 2, representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Microbiota compositions in percent relative abundance between healthy control and stroke patient individuals (the average microbiota between groups were displayed on the rightmost... by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Manifestations of Post-COVID-19 Conditions (PCC) three months post-acute illness, among those with PCC, by age group^a. by Chelsea S. Lutz (16001569)

Subjects:

Clinical outcomes and COVID-19 treatment during acute illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Additional file 6 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)